Apogee Therapeutics, Inc.
APGE
$39.94
$1.614.20%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -182.15M | -146.66M | -118.49M | -103.55M | -83.99M |
| Total Depreciation and Amortization | 189.00K | 113.00K | 65.00K | 29.00K | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12.79M | 6.86M | 5.41M | 3.59M | 3.12M |
| Change in Net Operating Assets | -2.00M | 6.48M | 2.44M | 4.10M | 6.11M |
| Cash from Operations | -171.17M | -133.21M | -110.57M | -95.84M | -74.76M |
| Capital Expenditure | -1.15M | -1.32M | -569.00K | -518.00K | -167.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -299.31M | -385.20M | -473.79M | -325.14M | -273.74M |
| Cash from Investing | -300.46M | -386.52M | -474.36M | -325.65M | -273.91M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 527.77M | 483.42M | 799.02M | 766.12M | 315.60M |
| Repurchase of Common Stock | -32.66M | -32.88M | -213.00K | -213.00K | -213.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | -31.35M | 0.00 | 0.00 |
| Cash from Financing | 495.11M | 450.54M | 767.46M | 765.91M | 315.39M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 23.47M | -69.20M | 182.52M | 344.42M | -33.28M |
